Practice Management
A new draft recommendation from the US Preventive Services Task Force (USPSTF) suggests that testing for human papilloma viruses (HPV) every 5 years starting at age 30 is a preferred screening strategy, emphasizing the need for testing for high-risk HPV with vaginal samples as opposed to the traditional cervical cytology pap tests. The USPSTF notes that the HPV test is more effective than a pap test as a cervical cancer screening tool for ages 30 …
Read More
New long-term data shows the human papillomavirus (HPV) vaccine introduced in 2006 to reduce the incidence of cervical cancer in women is having its intended effect. An observational study of 447,845 women in Scotland born between 1988 and 1996 revealed there were no cases of cervical cancer found among those who received the vaccine at age 12 or 13—even if the patient did not receive all 3 of the recommended doses. Those who were immunized …
Read More